Delivery Order SPE2DB22D1017-SPE2DB24FG3BN

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Viberzi 75 mg tablets. The contract has a firm fixed price of $1,925.98 and a completion date of November 29, 2024. The contract is not designated as a set-aside. This appears to be a task order against a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, to provide Viberzi 75 mg tablets. The contract has a firm fixed price of $1,650.57 and a completion date of August 15, 2024. It is not a set-aside contract. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the supply of a wide range of pharmaceutical and medical products to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg Viberzi tablets. The $2,648.37 firm-fixed-price contract has an ultimate completion date of October 10, 2024. AmerisourceBergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of essential pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 60 tablets of the medication Viberzi 75 mg, with a total ceiling value of $1,650.57. The contract is a firm fixed-price, delivery order contract with a completion date of July 29, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Viberzi 100 mg tablets. The contract has a firm fixed price of $2,133.20 and an ultimate completion date of August 23, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Viberzi 100 MG Tablet 60s. The contract has a ceiling value of $1,650.57 and is a Firm Fixed Price contract. The performance location is Conshohocken, PA. This contract is a child under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,450.84 firm-fixed-price contract is for the supply of the pharmaceutical product Viberzi 100 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,683,364 units of the medication VIBERZI 100 MG TABLET 60S. The contract has a ceiling value of $2,200.76 and runs through September 5, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,276.80 firm fixed-price delivery order is for the drug Viberzi 100mg tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,674.47 contract is for the delivery of 60 tablets of the drug Viberzi 75 mg. The contract has a completion date of June 7, 2023 and was awarded on June 6, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3BN
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565426528 Viberzi 100 mg tablets in 60-count packages. The $1,302.52 firm-fixed-price contract has an ultimate completion date of August 13, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999, for providing a wide range of pharmaceutical and medical supplies to support military treatment facilities and programs worldwide. The contract does not have a set-aside designation.

Generated 11/11/24, 9:08 AM